3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile

3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile acts as a reagent use in the synthesis of small molecular inhibitors that targets the catalytic domains of protein kinase that are not in active conformation.